Return to Course Library


Robert E. Lenkinski, PhD

Professor of Radiology
and Vice Chair of Radiology Research
UT Southwestern
Dallas, TX


Update on Gadolinium Deposition
and the Safety of MRI Contrast Agents

Coming to Tysons Corner, Virginia! (note: this is not a webinar)
Thursday | October 5, 2017

Hyatt Regency Tysons Corner Center
7901 Tysons One Place
Tysons Corner, Virginia, 22102

A certified one-hour lecture for radiologists, radiologic technologists, neuroradiologists, medical physicists, and referring physicians
Format: On-site Meeting in Tysons Corner, VA
Physician Credit: 1.0 AMA PRA Category 1
RT Credit: 1.0 ARRT Category A
Tuition: Free


5:30 - 6:00 pm Registration and light refreshments
6:00 - 7:00 pm Lecture and Discussion
    7:00 pm Adjourn

Data regarding gadolinium deposition in patients who have undergone contrast-enhanced MRI are rapidly evolving. Further research is needed to evaluate the clinical significance, if any, of these findings. In the meantime, radiologists and referring physicians must ensure informed decision-making about the benefits and potential risks to patients undergoing a contrast-enhanced MRI examination.

This lecture will discuss the physicochemical properties of gadolinium-based contrast agents, review pertinent literature, and discuss how recent data are relevant to clinical practice.

Educational Objectives
After completing this activity, the participants should be better able to:

  • Describe how the physicochemical properties and classification of GBCAs may affect patient safety
  • Discuss recent studies reporting the discovery of gadolinium deposits in patients who have undergone contrast-enhanced MRI exams
  • Summarize what is known and not known at this time regarding the clinical significance of gadolinium deposition in patients
  • Implement current FDA and ACR guidelines for GBCA usage

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Radiologic Technologist Continuing Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

Registration Information
REGISTER EARLY, a limited number of seats are available. Onsite registration is subject to space availabliity.

  • Click ENROLL NOW and follow the registration instructions to register with ICPME.
  • You will receive an email from ICPME confirming your registration.

How to Receive Credit

  1. Attend the entire lecture.
  2. Sign into your account at and click on the course title.
  3. Click the Evaluation tab on the left, complete the evaluation, and submit.
  4. Click the Certificate tab on the left, select the certificate type desired, and print.

Your Certificate of Credit will remain in your account at as a permanent record of your participation.

Robert E. Lenkinski, PhD
Professor of Radiology and Vice Chair of Radiology Research
UT Southwestern
Dallas, TX

Robert E. Lenkinski, PhD, is Professor of Radiology and Vice Chair of Radiology Research at UT Southwestern. He holds the Charles A. and Elizabeth Ann Sanders Chair in Translational Research, and the Jan and Bob Pickens Distinguished Professorship in Medical Science, in Memory of Jerry Knight Rymer and Annette Brannon Rymer and Mr. and Mrs. W.L. Pickens.

Before joining the faculty at UT Southwestern in 2011, Dr. Lenkinski served as Professor of Radiology at Harvard Medical School. Earlier academic appointments include Visiting Assistant Professor of Chemistry at the University of Houston, Research Assistant Professor of Psychology and Biophysics at the University of Illinois College of Medicine in Chicago, Assistant Professor of Biochemistry at the University of Alabama in Birmingham, Visiting Assistant Professor of Chemistry at the Weizmann Institute of Science, Associate Professor of Chemistry at the University of Guelph in Canada, and Associate Professor of Radiological Science at the University of Pennsylvania School of Medicine, where he received his first appointment in Radiology.

Dr. Lenkinski is a lanthanide chemist by training. A major focus of Dr. Lenkinski’s research involves developing, validating, and applying magnetic resonance spectroscopic (MRS) and multinuclear imaging methods for the study of human disease. He wants to understand how the metabolic information derived from these methods can aid in the diagnosis, staging, and treatment of a variety of pathologies. Current applications involve brain tumors, breast cancer, prostate cancer, and renal function.

Dr. Lenkinski is also investigating targeted molecular imaging agents, including lanthanide-based MRI relaxation and shift reagents and their conjugation to low-molecular weight ligands and their analogous PET tracers. He wants to develop targeted agents for imaging of micro-calcifications in human breast cancer.

Additional research involves the development and validation of a number of quantitative MRI methods, including arterial spin labeling, dynamic contrast-enhanced MRI, and diffusion weighted MRI for the study of human disease.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Robert E. Lenkinski, PhD has received consulting fees from Aspect Medical Imaging and has received a research grant from Philips Healthcare.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino Victoria Phoenix, BS
Trace Hutchison, PharmD Jan Schultz, RN, MSN, CHCP
Linda McLean, MS Judi Smelker-Mitchek, MBA, MSN, RN
Samantha Mattiucci, PharmD, CHCP  

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of products and devices that are not indicated by the FDA. The planners of this activity do not recommend the use of any products or devices outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Representatives from the International Center for Postgraduate Medical Education (ICPME) will be on site to assist you with meeting management and CME administration. If you require auxiliary aids or services identified in the Americans with Disabilities Act, please contact our office at (607) 257-5860 x10 at least 14 days prior to the this educational activity.

Queries and Comments
We welcome and encourage your comments on all aspects of this educational activity.

Please address your queries or comments regarding this activity to:
International Center for Postgraduate Medical Education
33 Thornwood Drive, Suite 400
Ithaca, NY 14850
Phone: 607-257-5860
Visit us on the web at


This activity is supported by an independent educational grant from Bayer HealthCare Pharmaceuticals.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.